Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 30, 2015 | MyoKardia | $46.0M Series B | — | BridgeBio, Casdin Capital, Cormorant Asset Management, Sanofi |
| Jan 6, 2015 | Global Blood Therapeutics | $48.0M Series B | — | William Slattery, RA Capital Management, Sabby Capital, Wellington Management |